PFS Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
PFS Partners's PFE Position: Q1 2026 in Review
PFS Partners reduced its Pfizer (PFE) stake by 8% in Q1 2026, selling an estimated $7.91K and leaving 3,420 shares worth $96K. The position accounts for 0.04% of the portfolio, ranked #126.
PFS Partners first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $256K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- PFS Partners held 3,420 shares of Pfizer worth $96K as of Q1 2026.
- PFS Partners sold 297 Pfizer shares in Q1 2026, an estimated $7.91K.
- Pfizer made up 0.04% of PFS Partners's portfolio in Q1 2026, its #126 holding.
- PFS Partners first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- PFS Partners's Pfizer position peaked at $256K in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on PFS Partners's 13F filing for Q1 2026, filed 9 Apr 2026.